RGT 1.79% 28.5¢ argent biopharma limited

Get rich on Cannabis!, page-47

  1. 65 Posts.
    Yes I did the same. I am hoping to get some research together (when I can find time) to analyse the potential market within Australia.

    Depending on data I will group by (as a non-medical expert):
    - Current generally accepted uses;
    - Quality of Life uses (if not generally accepted) - Spasticity, stroke, cancer (anti-tumour), parkinsons, chronic pain-terminal, cerebral palsy, epilepsy;
    - Mental illness uses (schizophrenia, anxiety);
    - Chronic pain (not terminal) - eg back injury while at work;
    - Common but less urgent by comparison (anti-inflammatory, substance abuse treatment);

    Cosmetic is something I don't aim to include as I don't know how any of it works.

    Key measures on market share/impact for me:
    - Conversion of opiate based prescriptions to cannabidiol based prescriptions;
    - Product sales where no existing treatment is effective;
    - Product sales where side-effects of existing drugs make cannibidiol more effective as a treatment;
    - Product sales where cannibidiol is a lower cost alternative to existing treatment.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
0.005(1.79%)
Mkt cap ! $13.79M
Open High Low Value Volume
28.5¢ 28.5¢ 28.5¢ $99 347

Buyers (Bids)

No. Vol. Price($)
2 14314 28.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 1000 1
View Market Depth
Last trade - 11.04am 26/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.